查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球血管移植市場
市場調查報告書
商品編碼
1279682

2023-2030 年全球血管移植市場

Global Vascular Graft Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

全球血管移植物市場預計將以有利的速度增長，到 2022 年將達到 24.833 億美元，到 2030 年將達到 44.04 億美元。 預計血管移植市場在預測期內（2023-2030 年）的複合年增長率為 7.6%。

血管移植物是一種醫療器械，可在血管旁路治療期間連接血管並引導血液從一個位置流向另一個位置。 在各種外科手術過程中，它有助於避免血管變窄，恢復受傷部位的血液流動，並避免心髒病發作和中風等問題。

心血管疾病發病率的增加、血管外科技術的進步、人口老齡化等預計將在預測期內促進全球血管移植市場的增長。

市場動態

預計透析手術數量的增加和慢性腎髒病 (CKD) 病例的增加將推動全球血管移植市場的增長。

全球透析手術數量的增加和慢性腎病 (CKD) 病例數量的增加正在推動全球血管移植市場的增長。 CKD 是一種退化性疾病，目前影響全球 8 億多人。 例如，根據 2022 年發表在《腎臟國際增刊雜誌》上的一項研究，CKD 患病率上升將增加透析過程中對血管移植物的需求。

此外，美國腎臟基金會報告稱，腎臟疾病影響了大約 3700 萬美國人，而腎衰竭是美國十大死因之一，影響了大約 810,000 人。據說會導致 因此，由於上述因素，全球血管移植市場將在預測期內呈現增長。

全球血管移植物市場或面臨血管□□移植物高成本的製約

血管移植物的高成本是全球血管移植物市場增長的主要製約因素。 血管移植物的價格根據所用材料的類型和手術的複雜程度而有所不同，例如，合成血管移植物往往比生物血管移植物便宜，但並不總是成功的。 因此，它是一種昂貴的產品，對於欠發達國家或沒有保險的患者來說可能負擔不起。

COVID-19 影響分析

由於業務運營、供應鏈、分銷系統等方面的中斷，COVID-19 爆發對血管移植物市場產生了負面影響。 其他擇期手術已被取消或推遲，以幫助遏制冠狀病毒的傳播。 此外，由於醫護人員專注於治療 COVID-19，因此非必要手術有所減少。

俄烏衝突分析

全球血管移植物市場並沒有受到俄羅斯和烏克蘭衝突的特別影響。 儘管衝突造成了地緣政治動盪和經濟制裁，但血管移植物的生產和分配在很大程度上不依賴於俄羅斯和烏克蘭。 血管移植市場的大多數參與者都是在世界各地設有辦事處和供應鏈的跨國公司。

血管移植物通常用於醫療目的，需求更多地是由患者需求和醫療保健法規驅動的，而不是地緣政治影響。 俄烏戰爭預計會對人工血管的可用性產生暫時和輕微的影響，但如果該地區的衝突和不穩定持續存在，包括人工血管市場在內的全球醫療保健部門將受到影響。它可以有行業產生廣泛影響。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章定義和概述

第 3 章執行摘要

  • 按產品分類
  • 按原材料
  • 最終用戶
  • 按地區

第四章市場動態

  • 影響因素
    • 主持人
      • 透析患者增加，慢性腎病 (CKD) 患者增加
    • 約束因素
      • 血管移植物的高成本
    • 機會
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 法律法規分析

第 6 章 COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情景
    • 當前的 COVID-19 情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格和動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章副產品

  • 血液透析通路移植物
  • 血管內動脈瘤修復覆膜支架
  • 外周血管移植

第 8 章按成分分類

  • 滌綸
  • 聚四氟乙烯 (PTFE)
  • 聚氨酯
  • 生物合成

第 9 章最終用戶

  • 醫院
  • 專科診所
  • 門診手術中心

第10章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第11章競爭格局

  • 競爭場景
  • 市場情況/份額分析
  • 併購分析

第12章公司簡介

  • 雅培實驗室
    • 公司簡介
    • 產品組合和說明
    • 財務摘要
    • 主要發展狀況
  • Braun Melsungen AG
  • Bard Peripheral Vascular Inc.（BD）
  • Cardinal Health（Cordis Corporation）
  • Cook Medical
  • Cryolife
  • Getinge Group
  • LeMaitre Vascular Inc
  • Medtronic PLC
  • W.L. Gore & Associates Inc

第13章 附錄

簡介目錄
Product Code: MD747

Market Overview

The global vascular graft market reached US$ 2,483.3 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 4,404.0 million by 2030. The vascular graft market is expected to exhibit a CAGR of 7.6% during the forecast period (2023-2030).

Vascular grafts are medical devices that connect blood vessels during vascular bypass treatments to redirect blood flow from one location to another. They help to circumvent constrictions in blood arteries, restore blood flow to injured areas, and avoid problems like heart attacks and strokes during a variety of surgical operations.

The rising frequency of cardiovascular illnesses, technical improvements in vascular surgery, and the aging population are all expected to contribute to the global vascular graft market growth over the forecast period.

Market Dynamics

The Rising Number of Dialysis Procedures and a Rise in Cases of Chronic Kidney Disease (CKD) Are Expected to Drive the Global Vascular Graft Market Growth.

The growing number of dialysis procedures and a rise in cases of chronic kidney disease (CKD) worldwide are driving the growth of the global vascular graft market. CKD is a degenerative disease that now affects more than 800 million people worldwide. For instance, according to research that was published in the Journal Kidney International Supplements in 2022, the rising prevalence of CKD will increase the demand for vascular grafts in dialysis procedures.

Furthermore, according to the report by the American Kidney Fund, renal disease affects approximately 37 million Americans, and kidney failure, one of the top 10 leading causes of mortality in the country, affects around 810,000 people. Therefore, owing to the above factors, the global vascular graft market will witness growth over the forecast period.

The Global Vascular Graft Market May Face Constraints Due to High Cost of Vascular Grafts.

The high cost associated with the vascular graft is the major restraint for global vascular graft market growth. The vascular graft prices vary based on the kind of material used and how complicated the surgery is, for instance, synthetic grafts tend to be less expensive than biological ones, but they might not always be as successful. The products could not be affordable for patients in underdeveloped nations or for those without insurance because of their high price.

COVID-19 Impact Analysis

Due to the disruption in business operations, supply chains, distribution systems, etc., the COVID-19 outbreak had a negative effect on the market for vascular grafts. In order to stop the coronavirus from spreading, other elective procedures were either cancelled or put off. Additionally, because healthcare providers were concentrating on COVID-19 treatment, fewer non-essential surgeries were performed.

Russia Ukraine Conflict Analysis

The world market for vascular grafts has not been specifically impacted by the conflict between Russia and Ukraine. Although the conflict has caused geopolitical unrest and economic sanctions, the production and distribution of vascular grafts are not heavily reliant on either Russia or Ukraine. The majority of the top market participants for vascular grafts are multinational corporations with operations and supply networks dispersed around the globe.

Vascular grafts are mostly employed in medical treatments, and rather than being influenced by geopolitics, the demand for these devices is largely driven by patient demands and healthcare regulations. The Russia-Ukraine war is only anticipated to have a transient and small-scale impact on the availability of vascular grafts, , but any prolonged conflict or instability in the region could have wider implications for the global healthcare industry, including the vascular grafts market.

Segment Analysis

The global vascular graft market is segmented based on product, raw material, end user, and region.

The Hospitals Segment is Expected to Dominate the Global Vascular Graft Market.

The hospitals sgement dominated the global vascular graft market and accounted the highest vascular graft market share of 38.3%. Vascular grafting is one of the many surgical procedures that have become more common in hospitals as a result of the rising burden of chronic illnesses including cardiovascular disease and chronic renal disease. As a result, hospitals make up the majority of vascular transplant end users.

The expansion of the hospital end user sector is also being fueled by the availability of public and private insurance programmes for hospital treatments. Vascular graft surgeries can be obtained by patients through insurance plans, which increases their accessibility and affordability. Therefore, owing to the above factors, the hospiatals segment is likely to play major role in accelarating the global vascular graft market growth.

Geographical Analysis

North America Region Holds The Largest Market Share of the Global Vascular Graft Market.

The global vascular graft market is dominated by North America and holds 1/3rd market share, due to the high prevalence of diabetes, cardiovascular disease, and chronic kidney disease. The expansion of this market in North America is being fueled by the presence of reimbursement coverage and the accessibility of cutting-edge healthcare infrastructure. The expansion of biomaterials vascular grafts is sparked by ongoing technical advancements that are followed by the identification of particular goods made via tissue engineering.

Furthermore, the better reimbursement policies, cutting-edge technology, effective initiatives, and precise diagnostic processes using biometric instruments are some of the major contributors to the market's growth. Moreover, it is anticipated that ongoing research into the creation of advanced biomaterial grafts will increase demand for these products in the area.

Competitive Landscape

The major global players in the market include: Abbott Laboratories, Braun Melsungen AG, Bard Peripheral Vascular Inc., Cardinal Health (Cordis Corporation), Cook Medical, Cryolife, Getinge Group, LeMaitre Vascular Inc, Medtronic PLC, and W.L. Gore & Associates Inc.

Why Purchase the Report?

  • To visualize the global vascular graft market segmentation based on product, raw material, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global vascular graft market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global vascular graft market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Raw Material
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rising number of dialysis procedures and a rise in cases of chronic kidney disease (CKD)
    • 4.1.2. Restraints
      • 4.1.2.1. High cost of vascular grafts.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Before COVID-19 Scenario
    • 6.1.2. Present COVID-19 Scenario
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Hemodialysis Access Graft
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Endovascular Aneurysm Repair Stent Graft
  • 7.4. Peripheral Vascular Graft

8. By Raw Material

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
    • 8.1.2. Market Attractiveness Index, By Raw Material
  • 8.2. Polyester
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Polytetrafluoroethylene (PTFE)
  • 8.4. Polyurethane
  • 8.5. Biosynthetic

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Specialty Clinics
  • 9.4. Ambulatory Surgery Center

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Abbott Laboratories*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Braun Melsungen AG
  • 12.3. Bard Peripheral Vascular Inc. (BD)
  • 12.4. Cardinal Health (Cordis Corporation)
  • 12.5. Cook Medical
  • 12.6. Cryolife
  • 12.7. Getinge Group
  • 12.8. LeMaitre Vascular Inc
  • 12.9. Medtronic PLC
  • 12.10. W.L. Gore & Associates Inc

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us